Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128872) titled 'Observational Study Following Flexible-dose Treatment with Buagafuran Capsule in Generalized Anxiety Disorder' on July 27.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing An Ding Hospital, Capital Medical University
Condition:
Generalized Anxiety Disorder (characterized by pervasive and persistent anxiety that is not confined to, or predominantly associated with, any specific external situation, also known as "free-floating anxiety". The following chief complaints are common: persistent nervousness, tremors, muscle tension, sweating, light-headedness, palpitations, dizzines...